Easy Touch Pen Needle 1/2 Leng

What is ETPN1229G Easy Touch Pen Needle 1/2 Leng?

The ETPN1229G Easy Touch Pen Needle 1/2 Leng is a 5mm insulin delivery needle engineered for reliable, comfortable subcutaneous injections. Manufactured by EasyTouch, this sterile, single-use needle is designed for individuals managing diabetes who require consistent, pain-free insulin administration. Its compact 1/2-inch length suits most adult and pediatric users, minimizing skin trauma while ensuring accurate dosing through a precise needle tip alignment.

Key features

• Universal Fit — Compatible with most standard insulin pen devices for seamless integration.
• 5mm Short Length — Reduces pain and skin trauma, ideal for daily self-injection.
• Film-Coated Bevel — Multi-facet needle tip with lubricated coating ensures smooth skin penetration.
• Electropolished Surface — Process removes micro-burrs, enhancing sharpness and reducing injection resistance.
• Latex-Free Construction — Safe for users with latex sensitivities; non-toxic and pyrogen-free.
• Sterile Packaging — Each needle is individually sealed to maintain hygiene and safety.
• Precision Alignment — Ensures consistent dosing and secure attachment to pen devices.

Who is ETPN1229G Easy Touch Pen Needle 1/2 Leng for?

This needle is ideal for people with type 1 or type 2 diabetes who use insulin pens for daily glucose control. It’s especially suited for those seeking reduced injection discomfort, including children, seniors, or needle-averse users. Its universal compatibility makes it a practical choice for households with multiple pen types or travelers needing reliable supplies.

How does ETPN1229G Easy Touch Pen Needle 1/2 Leng compare?

Compared to standard polypropylene insulin needles, the ETPN1229G offers enhanced comfort due to its lubricated, multi-facet bevel and electropolished shaft. While similar in length to other 5mm needles, its film coating reduces friction better than uncoated alternatives. It matches leading brands in universal fit and safety standards but delivers consistent performance at a competitive price point, making it a reliable mid-tier option for routine insulin therapy.